Valuation: Galenica AG

Market Cap 4.46B 5.32B 4.84B 4.06B 7.62B 493B 8.01B 54.33B 21.59B 269B 19.96B 19.54B 844B P/E 2026 *
26.8x
P/E 2027 * 21.5x
Enterprise Value 5.32B 6.34B 5.78B 4.84B 9.09B 588B 9.55B 64.81B 25.76B 321B 23.8B 23.3B 1,007B EV / Sales 2026 *
1.22x
EV / Sales 2027 * 1.17x
Free-Float
99.39%
Yield 2026 *
2.84%
Yield 2027 * 2.99%
1 day+0.90%
1 week-1.75%
Current month+1.88%
1 month+2.05%
3 months+8.34%
6 months+6.79%
Current year-8.29%
1 week 88.35
Extreme 88.35
92
1 month 86.3
Extreme 86.3
92
Current year 80.3
Extreme 80.3
103
1 year 80.3
Extreme 80.3
103
3 years 69.3
Extreme 69.3
103
5 years 60.55
Extreme 60.55
103
10 years 41.8
Extreme 41.8
103
Manager TitleAgeSince
Chief Executive Officer 59 2020-03-31
Director of Finance/CFO 44 2024-12-31
Chief Tech/Sci/R&D Officer 54 2021-12-31
Director TitleAgeSince
Director/Board Member 61 2017-12-31
Chairman 68 2023-05-02
Director/Board Member 49 2019-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
4/9/26 Sell 750 0.0015%
11/17/25 Buy 1 0.0000%
11/17/25 Buy 1 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.90%-1.75%+1.76%+27.00% 5.32B
-0.30%-6.68%+29.12%+125.42% 1,200B
+1.25%-5.35%+33.19%+80.42% 651B
+0.94%-2.99%+24.73%+106.93% 506B
-0.60%-1.95%+27.26%+67.32% 377B
+0.69%-9.50%+40.80%+30.23% 330B
+0.41%-4.70%+27.23%+51.59% 288B
+0.81%-4.08%-1.74%+32.71% 272B
-0.15%-6.45%+29.63%+64.18% 236B
-0.06%-0.98%+33.15%+118.99% 206B
Average +0.42%-4.46%+24.51%+70.48% 407B
Weighted average by Cap. +0.40%-5.19%+28.00%+87.41%

Financials

2026 *2027 *
Net sales 4.37B 5.2B 4.74B 3.97B 7.45B 482B 7.83B 53.15B 21.12B 263B 19.52B 19.11B 826B 4.52B 5.39B 4.91B 4.11B 7.72B 499B 8.11B 55.03B 21.87B 272B 20.21B 19.79B 855B
Net income 168M 200M 182M 153M 286M 18.51B 301M 2.04B 811M 10.11B 750M 734M 31.72B 207M 246M 224M 188M 353M 22.82B 371M 2.52B 1B 12.46B 925M 905M 39.11B
Net Debt 860M 1.03B 934M 783M 1.47B 94.94B 1.54B 10.47B 4.16B 51.85B 3.85B 3.77B 163B 809M 963M 877M 735M 1.38B 89.21B 1.45B 9.84B 3.91B 48.73B 3.61B 3.54B 153B
Projected Income Statement - Annual - Galenica AG
Logo Galenica AG
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Employees
6,623
Date Price Change Volume
26-11-20 CHF 89.60 +0.90% 64,812
26-11-19 CHF 88.80 -1.22% 113,661
26-11-18 CHF 89.90 -0.44% 43,764
26-11-17 CHF 90.30 -1.20% 88,137
26-11-16 CHF 91.40 +0.22% 118,674
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Galenica AG
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
89.60CHF
Average target price
90.20CHF
Spread / Average Target
+0.67%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Galenica AG
  1. Stock Market
  2. Stocks
  3. GALE Stock